Lymph node dissection in bladder cancer. Impact on staging and prognosis

Area of Science:

• Urology
• Surgical Oncology
• Oncologic Pathology

Background:

• Lymph node dissection (LND) is crucial for staging and prognosis in radical cystectomy (RC) for bladder cancer.
• The optimal extent of LND, particularly its proximal limit, remains debated.
• Accurate nodal staging is essential for guiding treatment decisions and predicting outcomes.

Purpose of the Study:

• To determine the necessary extent of LND for accurate staging of nodal involvement in bladder cancer patients undergoing RC.
• To evaluate the prognostic impact of different LND extents on patient survival.
• To assess the value of extended LND compared to limited dissection.

Main Methods:

• Prospective enrollment of patients undergoing RC and LND to the inferior mesenteric artery, with detailed mapping of metastatic lymph nodes.
• Inclusion of a historical cohort with limited LND for comparative prognostic analysis.
• Standard pathological examination for lymph node metastasis identification and evaluation of molecular markers (KPNA2).

Main Results:

• Standard pathological examination reliably identifies lymph node metastasis.
• LND to the aortic bifurcation is sufficient for accurate staging; less extensive LND risks under-staging.
• Extended LND (pelvic and lower lumbar nodes) demonstrated a survival benefit of at least 5% and is recommended for all patients, irrespective of T-stage or neoadjuvant chemotherapy.
• Previous radiotherapy may render pelvic LND difficult and potentially unnecessary.

Conclusions:

• LND to the aortic bifurcation is adequate for staging bladder cancer after RC.
• Extended LND, encompassing pelvic and lower lumbar regions, improves prognosis and should be routinely performed.
• The prognostic impact of molecular markers like KPNA2 is best evaluated with accurate staging from extended LND.